Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 5
Submit an article Journal homepage
59
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma

Murray S. Webb Inex Pharmaceuticals Corporation 100-8900 Glenlyon Parkway, Burnaby, BC, Canada
,
David L. Saltman Inex Pharmaceuticals Corporation 100-8900 Glenlyon Parkway, Burnaby, BC, Canada
,
Joseph M. Connors British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
&
James H. Goldie British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6
Pages 975-982 | Published online: 01 Jul 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Larry Boehlke & Jane N Winter. (2006) Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug. Expert Opinion on Biological Therapy 6:4, pages 409-415.
Read now
Nicola Di Renzo, Maura Brugiatelli, Antonella Montanini, Maria Luigia Vigliotti, Giulia Cervetti, Anna Marina Liberati, Stefano Luminari, Pierangelo Spedini, Gianfranco Giglio & Massimo Federico. (2006) Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. Leukemia & Lymphoma 47:3, pages 473-479.
Read now

Articles from other publishers (8)

Yan XuJin WangWanggang ZhangJie LiuXingmei CaoAili HeYinxia ChenLiufang GuBo LeiPengyu ZhangXiaorong Ma. (2016) Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study. Medical Science Monitor 22, pages 4297-4311.
Crossref
Andrew Furness & Ruth Pettengell. (2013) Pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphoma. International Journal of Hematologic Oncology 2:4, pages 315-323.
Crossref
Ruth Pettengell, Bertrand Coiffier, Geetha Narayanan, Fernando Hurtado de Mendoza, Raghunadharao Digumarti, Henry Gomez, Pier Luigi Zinzani, Gary Schiller, David Rizzieri, Giles Boland, Paul Cernohous, Lixia Wang, Christine Kuepfer, Igor Gorbatchevsky & Jack W Singer. (2012) Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial. The Lancet Oncology 13:7, pages 696-706.
Crossref
M. A. Rodriguez, Robert Pytlik, Tomas Kozak, Mukesh Chhanabhai, Randy Gascoyne, Biao Lu, Steven R. Deitcher & Jane N. Winter. (2009) Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma. Cancer 115:15, pages 3475-3482.
Crossref
Andreas Engert, Rauol Herbrecht, Armando Santoro, Pier Luigi Zinzani & Igor Gorbatchevsky. (2006) EXTEND PIX301: A Phase III Randomized Trial of Pixantrone Versus Other Chemotherapeutic Agents as Third-Line Monotherapy in Patients with Relapsed, Aggressive Non-Hodgkin's Lymphoma. Clinical Lymphoma and Myeloma 7:2, pages 152-154.
Crossref
Hannes Müller-Beißenhirtz, Christoph Kasper, Holger Nückel & Ulrich Dührsen. (2005) Gemcitabine, vinorelbine and prednisone for refractory or relapsed aggressive lymphoma,results of a phase II single center study. Annals of Hematology 84:12, pages 796-801.
Crossref
S. Monfardini, S.M.L. Aversa, V. Zoli, L. Salvagno, A. Bianco, R. Bordonaro, G. Benevolo, M. Crugnola, G. Crivellari, P. Vivaldi, U. Basso & V. Torri. (2005) Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas. Annals of Oncology 16:8, pages 1352-1358.
Crossref
. (2002) Current Awareness in Hematological Oncology. Hematological Oncology 20:4, pages 189-196.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.